[PERSON]
Stéphane Bancel
Featured in 6 tracked stories · first seen
Situations
Moderna and Merck melanoma vaccine clinical trials
9 clusters · 443 sources · last updated
Latest: Moderna reports positive Phase III results for personalized cancer vaccine
Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target
FDA approval of Moderna mRNA influenza vaccine
3 clusters · 6 sources · last updated
Latest: FDA approves first mRNA influenza vaccine as regional vaccination efforts expand
The U.S. Food and Drug Administration (FDA) has approved Moderna’s mFLUSIVA, the first mRNA-powered influenza vaccine. This technology utilizes a genetic blueprint to produce viral proteins, offering a faster production
Moderna mRNA flu vaccine US approval
4 clusters · 68 sources · last updated
Latest: Moderna's mFLUSIVA receives FDA approval as first mRNA flu vaccine
In early August 2026, the U.S. Food and Drug Administration (FDA) authorized Moderna’s mRNA-based seasonal influenza vaccine, mFlusiva. On 6 August, the agency granted full approval for adults aged 50–64, based on a late
Also covered in
-
EU Commission confirms vaccine investments preceded certainty of success
[POLITICS] · 2 sources ·